USPTO Grants Patent for Novel Cancer Therapeutic Compounds
What happened
The United States Patent and Trademark Office granted a patent for a novel class of therapeutic compounds. This patent, titled "5-HYDROXY-1,4-NAPHTHALENEDIONE FOR USE IN THE TREATMENT OF CANCER," provides intellectual property protection for compounds designed to inhibit cancer cells and cancer stem cells. The compounds show therapeutic potential against breast and prostate cancers.
From equitybulls.com
Why it matters
The grant of this composition of matter patent establishes intellectual property protection for a novel therapeutic application. This milestone is significant for the research and development operations of the company receiving the patent.
The United States Patent and Trademark Office granted a new composition of matter patent to a company.
From equitybulls.com
Who's involved
- United States Patent and Trademark OfficeAgency that formally granted the patent for the novel therapeutic compounds
Keep exploring
The entities involved
-
United States Patent and Trademark Office
agency in the United States Department of Commerce